Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease of unknown cause occurring in adults and affecting approximately 5 million people worldwide. The American Thoracic Society 2015 guidelines provide recommendations for the treatment of patients with IPF, including supportive care measures such as oxygen therapy, pulmonary rehabilitation, gastric acid therapy, sleep apnea, vaccinations, lung transplant evaluation, and pulmonary hypertension assessment. A smart-phrase was developed that outlines the supportive care measures for the IPF patient, which was then implemented into a new patient clinic note in the electronic medical record. Documentation of the measures improved significantly after implementation of the smart-phrase.